Top Markets
Coin of the day
Cellectis S.A. Cellectis S.A.

Cellectis S.A.

ALCLS
Classifica tra le azioni #17187
Cellectis S.A., a clinical-stage biotechnology company founded in 1999 and... Cellectis S.A., a clinical-stage biotechnology company founded in 1999 and headquartered in Paris, France, concentrates on immuno-oncology. The firm engineers therapeutic solutions utilizing gene-edited T-cells, which are modified to display chimeric antigen receptors (CARs) for the specific identification and destruction of cancer cells. Its operations are divided into two principal segments: Therapeutics and Plants. The company's pipeline features several allogeneic CAR T-cell product candidates. These include UCART19, aimed at CD19-expressing hematologic malignancies such as acute lymphoblastic leukemia; ALLO-501 and ALLO-501A, developed to treat relapsed or refractory diffuse large B-cell lymphoma and follicular lymphoma; ALLO-316, targeting renal cell carcinoma; UCART123, for acute myeloid leukemia; and UCART22, addressing B-cell acute lymphoblastic leukemia. Additionally, Cellectis is advancing UCARTCS1 and ALLO-715 for the treatment of multiple myeloma. Cellectis has forged significant strategic partnerships and alliances with companies including Allogene Therapeutics, Inc., Les Laboratoires Servier, The University of Texas M.D. Anderson Cancer Center, and Iovance Biotherapeutics. It also maintains a strategic research and development collaboration with Cytovia Therapeutics, Inc.
Prezzo delle azioni
$3.55
Capitalizzazione di mercato
$256.68M
Variazione (1 giorno)
4.98%
Variazione (1 anno)
37.99%
Paese
FR
Scambia Cellectis S.A. (ALCLS)

Categoria

Storico del prezzo dell'azione per Cellectis S.A. (ALCLS)
Prezzo di chiusura più alto: $3.46 il 2026-09-01

Prezzo di chiusura più basso: $17.72 il 2007-02-01
Storico del prezzo dell'azione di Cellectis S.A. dal 2007 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -20.49%
2025 169.48%
2024 -42.86%
2023 40.69%
2022 -74.52%
2021 -70.75%
2020 74.88%
2019 -10.96%
2018 -29.07%
2017 53.46%
2016 -41.97%
2015 106.63%
2014 307.22%
2013 -61.60%
2012 7.76%
2011 -4.53%
2010 -42.92%
2009 103.43%
2008 -44.49%
2007 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$553.36 37.99%
US
$1.06K 49.97%
NL
$155.59 543.18%
US
$122.21 -10.03%
AU
$762.65 8.90%
CH